Synthetic validation environment — no real patient data. Physician adjudication required.
Biod Clinical Pattern Engine · Validation Beta

Structured clinical
pattern analysis.

Transforming structured laboratory data into traceable clinical reasoning — deterministic, explainable, and built for interpretable diagnostic support under independent physician review.

Synthetic validation environment · physician adjudication required.

3
Clinical Engines in Validation
56
Validation Scenarios
79
Traceable Clinical Rules
OFF
Sandbox by Default
System Integrity

Engine status & rule coverage

Clinical Engines
3 Active
CPE-001 Thyroid · CPE-002 Metabolic
Traceable Clinical Rules
79
Sandbox OFF by default · 4 rules gated
Validation Coverage
56 scenarios
Deterministic synthetic suite
Platform Release
Validation Beta
External clinical review pending
Platform Architecture

Clinical Intelligence Modules

A multi-engine diagnostic infrastructure. Each module is an independent, deterministic Clinical Pattern Engine — released only after canonical rule validation. New engines join the ecosystem as their acceptance suites mature.

Synthetic Acceptance CompleteIn ValidationValidation BetaComing SoonRestricted
CPE-001
Thyroid Intelligence
Synthetic Acceptance Complete

Deterministic functional-state recognition across primary, central, subclinical, and thyrotoxic patterns with pregnancy, fertility, and assay-interference context modules.

Biomarkers Covered
TSHFT4FT3Anti-TPOAnti-TgTRAb
Validation Stage
7 traceable clinical rules · 15 validation scenarios
Synthetic Acceptance Suite Complete · external clinical review pendingOpen Module
CPE-002
Insulin Resistance–Associated Metabolic Pattern Intelligence
Validation Beta

Deterministic recognition of formal dysglycemia states, metabolic syndrome criteria, and explainable metabolic patterns associated with insulin resistance — with safety routing and physician adjudication required.

Biomarkers Covered
FPGHbA1cOGTTTGHDL-CWaistBPInsulin*HOMA-IR*
Validation Stage
37 traceable clinical rules · 21 validation scenarios · Sandbox OFF by default
Validation Beta · external clinical review pendingOpen Module
Upcoming
Anemia Pattern Engine
Coming Soon

Morphologic and kinetic classification of anemia patterns — pending roadmap governance. ID not yet assigned.

Biomarkers Covered
HgbMCVMCHRDWReticulocytesHaptoglobin
Validation Stage
Upcoming · ID pending roadmap governance
RoadmapComing Soon
CPE-003
Chronic Kidney Disease Intelligence
Validation Beta

Deterministic CGA classification (Cause + GFR + Albuminuria) with AKI safety gates, chronicity confirmation, validated KFRE eligibility, and medication-safety routing. Race-free CKD-EPI 2021 equations. Never confirms CKD from a single abnormal lab.

Biomarkers Covered
CreatinineCystatin CeGFRUACRK+Bicarbonate
Validation Stage
35 traceable clinical rules · 20 validation scenarios
Validation Beta · external clinical review pendingOpen Module
CPE-004
Inflammatory Activity
Coming Soon

Acute and chronic inflammatory pattern surveillance with cross-domain context for autoimmune, infectious, and metabolic drivers.

Biomarkers Covered
CRPESRFerritinWBCFibrinogen
Validation Stage
Module specification phase
RoadmapComing Soon
CPE-006
Lipid & Cardiometabolic
Coming Soon

ASCVD-risk-aware lipid pattern interpretation with apoB, Lp(a), and remnant-cholesterol stratification context.

Biomarkers Covered
LDL-CHDL-CApoBLp(a)TriglyceridesNon-HDL-C
Validation Stage
Module specification phase
RoadmapComing Soon
CPE-007
Adrenal Axis
Coming Soon

HPA-axis pattern recognition for primary and secondary adrenal insufficiency, with cortisol dynamics and ACTH context routing.

Biomarkers Covered
Cortisol 8AMACTHDHEA-SAldosteroneRenin
Validation Stage
Module specification phase
RoadmapComing Soon
CPE-008
Pituitary Axis
Coming Soon

Anterior-pituitary multi-axis pattern surveillance integrating gonadotropic, somatotropic, lactotropic, and thyrotropic signals.

Biomarkers Covered
LHFSHProlactinIGF-1TSHACTH
Validation Stage
Module specification phase
RoadmapComing Soon
CPE-009
Autoimmune Signals
Coming Soon

Cross-organ autoimmune pattern detection — thyroid, hepatic, rheumatologic, celiac — with shared-serology disambiguation.

Biomarkers Covered
ANAAnti-TPOAnti-tTGAnti-CCPRFComplement
Validation Stage
Module specification phase
RoadmapComing Soon
CPE-010
CBC Pattern Intelligence
Coming Soon

Full hematologic pattern recognition across red, white, and platelet lineages with morphologic flag integration.

Biomarkers Covered
WBCRBCHgbPlateletsNeutrophilsLymphocytes
Validation Stage
Module specification phase
RoadmapComing Soon
CPE-011
Liver Function Patterns
Coming Soon

Hepatocellular, cholestatic, and infiltrative pattern interpretation with synthetic-function and fibrosis-context routing.

Biomarkers Covered
ALTASTALPGGTBilirubinAlbuminINR
Validation Stage
Module specification phase
RoadmapComing Soon
CPE-012
Renal Function Patterns
Coming Soon

CKD staging and acute-kidney-injury pattern recognition with eGFR trajectory and proteinuria-context integration.

Biomarkers Covered
CreatinineeGFRBUNCystatin CUACRElectrolytes
Validation Stage
Module specification phase
RoadmapComing Soon
CPE-013
Functional Longevity Signals
Restricted

Healthspan-oriented multi-system pattern surveillance integrating metabolic, inflammatory, and endocrine longevity biomarkers.

Biomarkers Covered
hs-CRPHbA1cApoBIGF-1HomocysteineVit D
Validation Stage
Research-restricted · not for clinical use
RoadmapResearch Restricted
Functional state, not labels

Overt, subclinical, central, thyrotoxicosis, euthyroid autoimmune — each routed through deterministic rules PR-HT-01 through PR-HT-07, with etiology kept separate from biochemical state.

Every output is auditable

Every analysis discloses the rules that fired, the documented findings that triggered them, the evidence references, and the CPE version that produced the result.

Safety-aware by design

Adrenal-axis review before LT4 in central pattern. Pregnancy, fertility, postpartum, drug, and biotin interference contexts each route through dedicated modules.